{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:52:12Z","timestamp":1781617932114,"version":"3.54.5"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with rare diseases (RD) may present to the emergency department (ED) with an acute manifestation of an undiagnosed RD. If not identified, some of these patients may suffer from increased morbidity, mortality and worse outcomes compared to patients with more common diseases. Unfortunately, patients with RD often present with common symptoms, e.g. abdominal pain, making it even more difficult for ED physicians to identify those patients. Thus, strategies are needed to determine when certain RD should be suspected in the ED. We aimed to identify common features of RD through a systematised literature review of a predefined set of RD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Embase and MEDLINE were searched for eligible studies published in all years up to November 2023. Studies reporting clinical characteristics of patients who presented to the ED with one out of a predefined set of eight RD were included: acute hepatic porphyria, Fabry disease, familial Mediterranean fever, hereditary angioedema, hereditary hemorrhagic telangiectasia, myasthenia gravis, paroxysmal nocturnal hemoglobinuria and thrombotic thrombocytopenic purpura. Clinical characteristics, symptoms and family history were extracted to explore potential common features. Database searches, title, abstract and full-text screening and data extraction were conducted by a single reviewer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 4 732 articles identified, 18 were included in the review. For two RD no articles and for three RD only one article could be included. All but two prospective studies were retrospective chart reviews or case series reporting on small patient cohorts (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093 - 75 patients). The common features of patients were: age under 65\u2009years, recurrent symptoms affecting multiple organ systems, normal or nonspecific findings in routine laboratory tests and imaging, presence of trigger factors and a positive family history of similar symptoms or RD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review highlights the limited knowledge about RD in the ED setting. Some common features of RD patients were identified that could aid future research in developing risk stratification algorithms to facilitate early detection and treatment of RD in the ED. To our knowledge, this is the first literature review to explore the common features of patients with RD in the ED.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04111-6","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:28:44Z","timestamp":1763044124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Common features of rare disease patients in the emergency department: a systematised literature review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2949-2210","authenticated-orcid":false,"given":"Sandra","family":"Pflock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Carolina","family":"M\u00fccke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-9337","authenticated-orcid":false,"given":"Eva","family":"Diehl-Wiesenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"4111_CR1","unstructured":"What is EM? European Society for Emergency Medicine. https:\/\/eusem.org\/about-us\/emergency-medicine\/what-is-em. Accessed 18 March 2025."},{"issue":"7","key":"4111_CR2","doi-asserted-by":"publisher","first-page":"e062126","DOI":"10.1136\/bmjopen-2022-062126","volume":"12","author":"GM Abozaid","year":"2022","unstructured":"Abozaid GM, Kerr K, McKnight A, Al-Omar HA. Criteria to define rare diseases and orphan drugs: a systematic review protocol. BMJ Open. 2022;12(7):e062126.","journal-title":"BMJ Open"},{"key":"4111_CR3","unstructured":"Official Journal of the European Communities. Commission regulation (ec) No 847\/2000. 2000. https:\/\/eur-lex.europa.eu\/resource.html?uri=cellar:208111e4-414e-4da5-94c1-852f1c74f351.0008.02\/DOC_1%26format=PDF. Accessed 17 April 2025."},{"key":"4111_CR4","unstructured":"Office of the Commissioner. Orphan Drug Act - relevant Excerpts. U.S. Food and Drug administration. 2013. https:\/\/www.fda.gov\/industry\/designating-orphan-product-drugs-and-biological-products\/orphan-drug-act-relevant-excerpts. Accessed 12 December 2024."},{"issue":"6","key":"4111_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","volume":"18","author":"T Richter","year":"2015","unstructured":"Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, et al. Rare disease terminology and definitions-A systematic global review: report of the ispor rare disease special interest group. Value Health. 2015;18(6):906\u201314.","journal-title":"Value Health"},{"issue":"2","key":"4111_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","volume":"19","author":"M Haendel","year":"2020","unstructured":"Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"4111_CR7","unstructured":"European Commission. Rare diseases. https:\/\/health.ec.europa.eu\/rare-diseases-and-european-reference-networks\/rare-diseases_en. Accessed 17 April 2025."},{"issue":"2","key":"4111_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165\u201373.","journal-title":"Eur J Hum Genet"},{"key":"4111_CR9","unstructured":"CDC\/National Center for Health Statistics. Emergency Department Visits. 2024. https:\/\/www.cdc.gov\/nchs\/fastats\/emergency-department.htm. Accessed 17 April 2025."},{"key":"4111_CR10","unstructured":"Reform der Notfall- und Akutversorgung in Deutschland. Integrierte Notfallzentren und Integrierte Leitstellen [Reform of emergency and acute care in Germany. Integrated emergency centres and integrated control centres]. 2023. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/K\/Krankenhausreform\/Vierte_Stellungnahme_Regierungskommission_Notfall_ILS_und_INZ.pdf. Accessed 17 April 2025."},{"key":"4111_CR11","unstructured":"Statista Research Department. Number of visits registered by the emergency services in France from 2017 to 2022 2023. https:\/\/www.statista.com\/statistics\/1369429\/number-of-emergency-visits-in-france\/. Accessed 17 April 2025."},{"key":"4111_CR12","doi-asserted-by":"crossref","unstructured":"Adachi T, El-Hattab AW, Jain R, Nogales Crespo KA, Quirland Lazo CI, Scarpa M, et al. Enhancing equitable access to rare disease diagnosis and treatment around the world: a review of evidence, policies, and challenges. Int J Environ Res Public Health. 2023;20(6)","DOI":"10.3390\/ijerph20064732"},{"key":"4111_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-90-481-9485-8_14","volume":"686","author":"A Kole","year":"2010","unstructured":"Kole A, Faurisson F. Rare diseases social epidemiology: analysis of inequalities. Adv Exp Med Biol. 2010;686:223\u201350.","journal-title":"Adv Exp Med Biol"},{"key":"4111_CR14","doi-asserted-by":"crossref","unstructured":"Faye F, Crocione C, Anido de Pena R, Bellagambi S, Escati Penaloza L, Hunter A, et al. Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a rare barometer retrospective patient survey. Eur J Hum Genet. 2024.","DOI":"10.1038\/s41431-024-01604-z"},{"key":"4111_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1750-1172-9-37","volume":"9","author":"M Mazzucato","year":"2014","unstructured":"Mazzucato M, Visona Dalla Pozza L, Manea S, Minichiello C, Facchin P. A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region\u2019s rare diseases registry. Orphanet J Rare Dis. 2014;9:37.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4111_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13023-023-02944-7","volume":"18","author":"M Mazzucato","year":"2023","unstructured":"Mazzucato M, Visona Dalla Pozza L, Minichiello C, Toto E, Vianello A, Facchin P. Estimating mortality in rare diseases using a population-based registry, 2002 through 2019. Orphanet J Rare Dis. 2023;18(1):362.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"4111_CR17","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/s41436-021-01241-7","volume":"23","author":"AA Navarrete-Opazo","year":"2021","unstructured":"Navarrete-Opazo AA, Singh M, Tisdale A, Cutillo CM, Garrison SR. Can you hear us now? The impact of health-care utilization by rare disease patients in the United States. Genet Med. 2021;23(11):2194\u2013201.","journal-title":"Genet Med"},{"issue":"1","key":"4111_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13023-021-01737-0","volume":"16","author":"RM Blazsik","year":"2021","unstructured":"Blazsik RM, Beeler PE, Tarcak K, Cheetham M, von Wyl V, Dressel H. Impact of single and combined rare diseases on adult inpatient outcomes: a retrospective, cross-sectional study of a large inpatient population. Orphanet J Rare Dis. 2021;16(1):105.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"4111_CR19","doi-asserted-by":"publisher","first-page":"e0265847","DOI":"10.1371\/journal.pone.0265847","volume":"17","author":"M Isono","year":"2022","unstructured":"Isono M, Kokado M, Kato K. Why does it take so long for rare disease patients to get an accurate diagnosis?-A qualitative investigation of patient experiences of hereditary angioedema. PLoS One. 2022;17(3):e0265847.","journal-title":"PLoS One"},{"issue":"1","key":"4111_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13023-022-02354-1","volume":"17","author":"L Zhou","year":"2022","unstructured":"Zhou L, Xu J, Yang J. Poor education and urgent information need for emergency physicians about rare diseases in China. Orphanet J Rare Dis. 2022;17(1):211.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4111_CR21","doi-asserted-by":"publisher","first-page":"O15","DOI":"10.1186\/1750-1172-9-S1-O15","volume":"9","author":"V Faucounneau","year":"2014","unstructured":"Faucounneau V, Rath A. Emergency guidelines and emergency cards. Orphanet J Rare Dis. 2014;9(1):O15.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4111_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jaip.2019.05.056","volume":"8","author":"S Betschel","year":"2020","unstructured":"Betschel S, Avilla E, Kanani A, Kastner M, Keith P, Binkley K, et al. Development of the hereditary angioedema rapid triage tool. J Allergy Clin Immunol Pract. 2020;8(1):310\u20137 e3.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4111_CR23","doi-asserted-by":"crossref","unstructured":"Solares I, Heredia-Mena C, Castelbon FJ, Jerico D, Cordoba KM, Fontanellas A, et al. Diagnosis and management of inborn errors of metabolism in adult patients in the emergency department. Diagn (Basel). 2021;11(11)","DOI":"10.3390\/diagnostics11112148"},{"issue":"4","key":"4111_CR24","first-page":"S44","volume":"29","author":"S Masatlioglu","year":"2011","unstructured":"Masatlioglu S, Dulundu E, Gogus F, Hatemi G, Ozdogan H. The frequency of familial Mediterranean fever in an emergency unit. Clin Exp Rheumatol. 2011;29(4):S44\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"4111_CR25","doi-asserted-by":"publisher","first-page":"e6109","DOI":"10.1097\/MD.0000000000006109","volume":"96","author":"T Hirose","year":"2017","unstructured":"Hirose T, Kimbara F, Shinozaki M, Mizushima Y, Yamamoto H, Kishi M, et al. Screening for hereditary angioedema (hae) at 13 emergency centers in Osaka, Japan: a prospective observational study. Med (Baltim). 2017;96(6):e6109.","journal-title":"Med (Baltim)"},{"issue":"1","key":"4111_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13023-023-02768-5","volume":"18","author":"E Diehl-Wiesenecker","year":"2023","unstructured":"Diehl-Wiesenecker E, Blaschke S, Wohmann N, Kubisch I, Stauch T, Mainert M, et al. Detect acute porphyrias in emergency departments (DePored) - a pilot study. Orphanet J Rare Dis. 2023;18(1):146.","journal-title":"Orphanet J Rare Dis"},{"key":"4111_CR27","doi-asserted-by":"crossref","unstructured":"Chirmule N, Feng H, Cyril E, Ghalsasi VV, Choudhury MC. Orphan drug development: challenges, regulation, and success stories. J Biosci. 2024;49.","DOI":"10.1007\/s12038-024-00425-y"},{"issue":"1","key":"4111_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-019-1075-8","volume":"14","author":"L Vandeborne","year":"2019","unstructured":"Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14(1):99.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"4111_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","volume":"36","author":"G Elder","year":"2013","unstructured":"Elder G, Harper P, Badminton M, Sandberg S, Deybach JC. The incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2013;36(5):849\u201357.","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"4111_CR30","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","volume":"127","author":"HL Bonkovsky","year":"2014","unstructured":"Bonkovsky HL, Maddukuri VC, Yazici C, Anderson KE, Bissell DM, Bloomer JR, et al. Acute porphyrias in the Usa: features of 108 subjects from porphyrias consortium. Am J Med. 2014;127(12):1233\u201341.","journal-title":"Am J Med"},{"issue":"2","key":"4111_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1365-2796.2003.01172.x","volume":"254","author":"C Andersson","year":"2003","unstructured":"Andersson C, Innala E, Backstrom T. Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden. J Intern Med. 2003;254(2):176\u201383.","journal-title":"J Intern Med"},{"key":"4111_CR32","first-page":"3701","volume-title":"Harrisons Innere Medizin [Harrison\u2019s principles of internal medicine, German edition]. 20th ed","author":"E Diehl-Wiesenecker","year":"2020","unstructured":"Diehl-Wiesenecker E, Somasundaram R. 409 Die Porphyrien [The porphyrias]. In: Suttorp N, M\u00f6ckel M, Siegmund B, Dietel M, editors. Harrisons Innere Medizin [Harrison\u2019s principles of internal medicine, German edition]. 20th ed. ABW Verlag; 2020. p. 3701\u201314."},{"issue":"2","key":"4111_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.gastro.2019.04.050","volume":"157","author":"U Stolzel","year":"2019","unstructured":"Stolzel U, Doss MO, Schuppan D. Clinical Guide and update on porphyrias. Gastroenterology. 2019;157(2):365\u201381 e4.","journal-title":"Gastroenterology"},{"issue":"1","key":"4111_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/liv.15090","volume":"42","author":"P Ventura","year":"2022","unstructured":"Ventura P, Bonkovsky HL, Gouya L, Aguilera-Peiro P, Montgomery Bissell D, Stein PE, et al. Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 envision study. Liver Int. 2022;42(1):161\u201372.","journal-title":"Liver Int"},{"issue":"19","key":"4111_CR35","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1182\/blood.2022018662","volume":"142","author":"M Yasuda","year":"2023","unstructured":"Yasuda M, Keel S, Balwani M. Rna interference therapy in acute hepatic porphyrias. Blood. 2023;142(19):1589\u201399.","journal-title":"Blood"},{"issue":"5","key":"4111_CR36","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2016090964","volume":"28","author":"M Arends","year":"2017","unstructured":"Arends M, Wanner C, Hughes D, Mehta A, Oder D, Watkinson OT, et al. Characterization of classical and nonclassical fabry disease: a multicenter study. J Am Soc Nephrol. 2017;28(5):1631\u201341.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"4111_CR37","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","volume":"24","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R, Warnock DG, Banikazemi M, Bultas J, Linthorst GE, Packman S, et al. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transpl. 2009;24(7):2102\u201311.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"4111_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","volume":"30","author":"CM Eng","year":"2007","unstructured":"Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO, et al. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the fabry registry. J Inherit Metab Dis. 2007;30(2):184\u201392.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"4111_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. Jama. 1999;281(3):249\u201354.","journal-title":"Jama"},{"issue":"1\u20132","key":"4111_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"BJ Poorthuis","year":"1999","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. The frequency of lysosomal storage diseases in the Netherlands. Hum Genet. 1999;105(1\u20132):151\u201356.","journal-title":"Hum Genet"},{"key":"4111_CR41","doi-asserted-by":"publisher","first-page":"1341590","DOI":"10.3389\/fcvm.2024.1341590","volume":"11","author":"J Gambardella","year":"2024","unstructured":"Gambardella J, Riccio E, Bianco A, Fiordelisi A, Cerasuolo FA, Buonaiuto A, et al. Fatigue as hallmark of fabry disease: role of bioenergetic alterations. Front. Cardiovasc. Med. 2024;11:1341590.","journal-title":"Front. Cardiovasc. Med"},{"key":"4111_CR42","unstructured":"\u00dc\u00e7eyler N, Abicht A, Beck M, Brand E, J\u00fcnemann A, Vom Dah S. Diagnose und Therapie des Morbus Fabry, S1-Leitlinie. [Diagnosis and treatment of fabry disease, S1 guideline]. Deutsche Gesellschaft f\u00fcr Neurologie Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. 2022. https:\/\/register.awmf.org\/assets\/guidelines\/030-134l_S1_Diagnostik-Therapie-Morbus-Fabry_2023-02.pdf. Accessed 1 June 2024."},{"key":"4111_CR43","unstructured":"Belmatoug N, Bagou G. Orphanet emergencies. Maladie de Fabry [Fabry disease]. 2011. https:\/\/www.orpha.net\/pdfs\/data\/patho\/Pro\/fr\/Urgences_Fabry.pdf. Accessed 19 April 2025."},{"issue":"9103","key":"4111_CR44","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","volume":"351","author":"E Ben-Chetrit","year":"1998","unstructured":"Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351(9103):659\u201364.","journal-title":"Lancet"},{"key":"4111_CR45","doi-asserted-by":"crossref","unstructured":"Aydin O, Egeli BH, Ozdogan H, Ugurlu S. Late-onset familial mediterranean fever: single-center experience and literature review. Intern Emerg Med. 2022.","DOI":"10.1007\/s11739-021-02912-8"},{"issue":"2","key":"4111_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","volume":"43","author":"E Sohar","year":"1967","unstructured":"Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227\u201353.","journal-title":"Am J Med"},{"issue":"10","key":"4111_CR47","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/art.24458","volume":"61","author":"E Ben-Chetrit","year":"2009","unstructured":"Ben-Chetrit E, Touitou I. Familial mediterranean fever in the world. Arthritis Rheum. 2009;61(10):1447\u201353.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4111_CR48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/rheumatology\/kew058","volume":"56","author":"DM Rowczenio","year":"2017","unstructured":"Rowczenio DM, Iancu DS, Trojer H, Gilbertson JA, Gillmore JD, Wechalekar AD, et al. Autosomal dominant familial Mediterranean fever in Northern European caucasians associated with deletion of p.M694 residue-a case series and genetic exploration. Rheumatol (Oxford). 2017;56(2):209\u201313.","journal-title":"Rheumatol (Oxford)"},{"issue":"3","key":"4111_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/GIM.0b013e31820e27b1","volume":"13","author":"N Zadeh","year":"2011","unstructured":"Zadeh N, Getzug T, Grody WW. Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic. Genet Med. 2011;13(3):263\u201369.","journal-title":"Genet Med"},{"key":"4111_CR50","doi-asserted-by":"crossref","unstructured":"Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R, et al. An update on familial Mediterranean fever. Int J Mol Sci. 2023;24(11)","DOI":"10.3390\/ijms24119584"},{"issue":"4 Suppl 67","key":"4111_CR51","first-page":"S77","volume":"29","author":"MA Ozturk","year":"2011","unstructured":"Ozturk MA, Kanbay M, Kasapoglu B, Onat AM, Guz G, Furst DE, et al. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol. 2011;29(4 Suppl 67):S77\u201386.","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"4111_CR52","first-page":"1567","volume":"40","author":"F Kharouf","year":"2022","unstructured":"Kharouf F, Tsemach-Toren T, Ben-Chetrit E. IL-1 inhibition in familial Mediterranean fever: clinical outcomes and expectations. Clin Exp Rheumatol. 2022;40(8):1567\u201374.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"4111_CR53","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.revmed.2023.10.441","volume":"44","author":"S Georgin-Lavialle","year":"2023","unstructured":"Georgin-Lavialle S, Savey L, Cuisset L, Boursier G, Boffa JJ, Delplanque M, et al. French protocol for the diagnosis and management of familial Mediterranean fever. Rev Med Interne. 2023;44(11):602\u201316.","journal-title":"Rev Med Interne"},{"issue":"4","key":"4111_CR54","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644\u201351.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4111_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13023-018-0815-5","volume":"13","author":"E Aygoren-Pursun","year":"2018","unstructured":"Aygoren-Pursun E, Magerl M, Maetzel A, Maurer M. Epidemiology of bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis. 2018;13(1):73.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"4111_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","volume":"119","author":"K Bork","year":"2006","unstructured":"Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267\u201374.","journal-title":"Am J Med"},{"issue":"7","key":"4111_CR57","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/all.15214","volume":"77","author":"M Maurer","year":"2022","unstructured":"Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui IJ, Aygoren-Pursun E, et al. The international WAO\/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update. Allergy. 2022;77(7):1961\u201390.","journal-title":"Allergy"},{"issue":"3","key":"4111_CR58","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ajmg.1320320302","volume":"32","author":"H Plauchu","year":"1989","unstructured":"Plauchu H, de Chadarevian Jp, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32(3):291\u201397.","journal-title":"Am J Med Genet"},{"issue":"2","key":"4111_CR59","first-page":"221","volume":"84","author":"MM Serra","year":"2024","unstructured":"Serra MM, Papi M, Serrano C. Prevalence of hereditary hemorrhagic telangiectasia in a medical care program organization in Buenos Aires, Argentina. Medicina (B Aires). 2024;84(2):221\u201326.","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"4111_CR60","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (rendu-osler-weber syndrome). Am J Med Genet. 2000;91(1):66\u201367.","journal-title":"Am J Med Genet"},{"issue":"4","key":"4111_CR61","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000479632","volume":"94","author":"S Dupuis-Girod","year":"2017","unstructured":"Dupuis-Girod S, Cottin V, Shovlin CL. The lung in hereditary hemorrhagic telangiectasia. Respiration. 2017;94(4):315\u201330.","journal-title":"Respiration"},{"issue":"1","key":"4111_CR62","doi-asserted-by":"publisher","first-page":"104370","DOI":"10.1016\/j.ejmg.2021.104370","volume":"65","author":"CL Shovlin","year":"2022","unstructured":"Shovlin CL, Buscarini E, Sabba C, Mager HJ, Kjeldsen AD, Pagella F, et al. The European rare disease network for HHT frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care. Eur J Med Genet. 2022;65(1):104370.","journal-title":"Eur J Med Genet"},{"issue":"2","key":"4111_CR63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48(2):73\u201387.","journal-title":"J Med Genet"},{"issue":"12","key":"4111_CR64","doi-asserted-by":"publisher","first-page":"989","DOI":"10.7326\/M20-1443","volume":"173","author":"ME Faughnan","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020;173(12):989\u20131001.","journal-title":"Ann Intern Med"},{"key":"4111_CR65","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, Po M, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010;10:46.","journal-title":"BMC Neurol"},{"issue":"1","key":"4111_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/JND-140045","volume":"2","author":"JC Deenen","year":"2015","unstructured":"Deenen JC, Horlings CG, Verschuuren JJ, Verbeek AL, van Engelen BG. The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis. 2015;2(1):73\u201385.","journal-title":"J Neuromuscul Dis"},{"key":"4111_CR67","doi-asserted-by":"crossref","unstructured":"Vissing J, Atula S, Savolainen M, Mehtala J, Mehkri L, Olesen TB, et al. Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational study. J Neurol Neurosurg Psychiatry. 2024.","DOI":"10.1136\/jnnp-2023-333097"},{"issue":"5","key":"4111_CR68","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neurol.2024.02.392","volume":"180","author":"S Keovilayhong","year":"2024","unstructured":"Keovilayhong S, Mulliez A, Feral L, Chenaf C, Clavelou P, Moisset X, et al. Epidemiology of myasthenia gravis in France: incidence, prevalence, and comorbidities based on national healthcare insurance claims data. Rev Neurol (paris). 2024;180(5):451\u201358.","journal-title":"Rev Neurol (paris)"},{"issue":"2","key":"4111_CR69","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","volume":"21","author":"AR Punga","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. The Lancet Neurol. 2022;21(2):176\u201388.","journal-title":"The Lancet Neurol"},{"issue":"12","key":"4111_CR70","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00415-018-9056-8","volume":"265","author":"F Li","year":"2018","unstructured":"Li F, Hotter B, Swierzy M, Ismail M, Meisel A, Ruckert JC. Generalization after ocular onset in myasthenia gravis: a case series in Germany. J Neurol. 2018;265(12):2773\u201382.","journal-title":"J Neurol"},{"issue":"6","key":"4111_CR71","doi-asserted-by":"publisher","first-page":"e16180","DOI":"10.1111\/ene.16180","volume":"31","author":"F Sacca","year":"2024","unstructured":"Sacca F, Salort-Campana E, Jacob S, Cortes-Vicente E, Schneider-Gold C. Refocusing generalized myasthenia gravis: patient burden, disease profiles, and the role of evolving therapy. Eur J Neurol. 2024;31(6):e16180.","journal-title":"Eur J Neurol"},{"key":"4111_CR72","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00063110-200512000-00017","volume":"12","author":"PB Smulowitz","year":"2005","unstructured":"Smulowitz PB, Zeller J, Sanchez LD, Edlow JA. Myasthenia gravis: lessons for the emergency physician. Eur J Emerg Med. 2005;12:324\u201326.","journal-title":"Eur J Emerg Med"},{"key":"4111_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42466-019-0023-3","volume":"1","author":"H Stetefeld","year":"2019","unstructured":"Stetefeld H, Schroeter M. Sop myasthenic crisis. Neurol Res Pract. 2019;1:19.","journal-title":"Neurol Res Pract"},{"issue":"4","key":"4111_CR74","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/acem.14861","volume":"31","author":"A Sivadasan","year":"2024","unstructured":"Sivadasan A, Ma C-L, Cortel-LeBlanc A, Katzberg H. Peripheral nervous system and neuromuscular disorders in the emergency department: a review. Acad Emerg Med. 2024;31(4):386\u201397.","journal-title":"Acad Emerg Med"},{"key":"4111_CR75","doi-asserted-by":"publisher","first-page":"175628642312132","DOI":"10.1177\/17562864231213240","volume":"16","author":"H Wiendl","year":"2023","unstructured":"Wiendl H, Abicht A, Chan A, Della Marina A, Hagenacker T, Hekmat K, et al. Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord. 2023;16:17562864231213240.","journal-title":"Ther Adv Neurol Disord"},{"issue":"19","key":"4111_CR76","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","volume":"333","author":"P Hillmen","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333(19):1253\u201358.","journal-title":"N Engl J Med"},{"issue":"1","key":"4111_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.13059","volume":"101","author":"A Roth","year":"2018","unstructured":"Roth A, Maciejewski J, Nishimura JI, Jain D, Weitz JI. Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: expert consensus. Eur J Haematol. 2018;101(1):3\u201311.","journal-title":"Eur J Haematol"},{"issue":"5","key":"4111_CR78","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3324\/haematol.2013.093161","volume":"99","author":"H Schrezenmeier","year":"2014","unstructured":"Schrezenmeier H, Muus P, Socie G, Szer J, Urbano-Ispizua A, Maciejewski JP, et al. Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal hemoglobinuria registry. Haematologica. 2014;99(5):922\u201329.","journal-title":"Haematologica"},{"issue":"2","key":"4111_CR79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/ejh.13640","volume":"107","author":"SJ Richards","year":"2021","unstructured":"Richards SJ, Painter D, Dickinson AJ, Griffin M, Munir T, Arnold L, et al. The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: a retrospective analysis of the UK\u2019s population-based haematological malignancy research network 2004-2018. Eur J Haematol. 2021;107(2):211\u201318.","journal-title":"Eur J Haematol"},{"issue":"4","key":"4111_CR80","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","volume":"73","author":"J Takeda","year":"1993","unstructured":"Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, et al. Deficiency of the gpi anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73(4):703\u201311.","journal-title":"Cell"},{"issue":"9027","key":"4111_CR81","first-page":"573","volume":"348","author":"G Socie","year":"1996","unstructured":"Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Fr Soc of Haematol. Lancet. 1996;348(9027):573\u201377.","journal-title":"Fr Soc Of Haematol. Lancet"},{"issue":"12","key":"4111_CR82","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106(12):3699\u2013709.","journal-title":"Blood"},{"issue":"6","key":"4111_CR83","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2141.2011.08690.x","volume":"153","author":"L Luzzatto","year":"2011","unstructured":"Luzzatto L, Gianfaldoni G, Notaro R. Management of paroxysmal nocturnal haemoglobinuria: a personal view. Br J Haematol. 2011;153(6):709\u201320.","journal-title":"Br J Haematol"},{"key":"4111_CR84","unstructured":"Soci\u00e9 G, Bagou G. Orphanet emergency guidelines. Paroxysmal nocturnal haemoglobinuria. 2008. https:\/\/www.orpha.net\/pdfs\/data\/patho\/Pro\/en\/Emergency_ParoxysmalNocturnalHaemoglobinuria.pdf. Accessed 19 April 2025."},{"key":"4111_CR85","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","volume":"3","author":"JA Kremer Hovinga","year":"2017","unstructured":"Kremer Hovinga JA, Coppo P, Lammle B, Moake JL, Miyata T, Vanhoorelbeke K. Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers. 2017;3:17020.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"4111_CR86","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5482\/HAMO-13-04-0026","volume":"33","author":"M Mansouri Taleghani","year":"2013","unstructured":"Mansouri Taleghani M, von Krogh as, Fujimura Y, George JN, Hrachovinova I, Knobl PN, et al. Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry. Hamostaseologie. 2013;33(2):138\u201343.","journal-title":"Hamostaseologie"},{"issue":"1","key":"4111_CR87","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13023-019-1240-0","volume":"14","author":"W Miesbach","year":"2019","unstructured":"Miesbach W, Menne J, Bommer M, Schonermarck U, Feldkamp T, Nitschke M, et al. Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study. Orphanet J Rare Dis. 2019;14(1):260.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"4111_CR88","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","volume":"15","author":"M Scully","year":"2017","unstructured":"Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J, et al. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2017;15(2):312\u201322.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"4111_CR89","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jemermed.2021.07.045","volume":"61","author":"B Long","year":"2021","unstructured":"Long B, Bridwell RE, Manchanda S, Gottlieb M. Evaluation and management of thrombotic Thrombocytopenic Purpura in the emergency department. J Emerg Med. 2021;61(6):674\u201382.","journal-title":"J Emerg Med"},{"issue":"10","key":"4111_CR90","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/jth.15009","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, et al. Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18(10):2503\u201312.","journal-title":"J Thromb Haemost"},{"issue":"10","key":"4111_CR91","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","volume":"130","author":"JE Sadler","year":"2017","unstructured":"Sadler JE. Pathophysiology of thrombotic thrombocytopenic purpura. Blood. 2017;130(10):1181\u201388.","journal-title":"Blood"},{"issue":"17","key":"4111_CR92","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","volume":"390","author":"M Scully","year":"2024","unstructured":"Scully M, Antun A, Cataland SR, Coppo P, Dossier C, Biebuyck N, et al. Recombinant ADAMTS13 in congenital thrombotic Thrombocytopenic Purpura. N Engl J Med. 2024;390(17):1584\u201396.","journal-title":"N Engl J Med"},{"issue":"10","key":"4111_CR93","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1111\/jth.15006","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, et al. Isth guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18(10):2486\u201395.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"4111_CR94","first-page":"176","volume":"22","author":"NG Munoz","year":"2024","unstructured":"Munoz NG, Ortega S, Solanich X, Cid J, Diaz M, Moreno AB, et al. Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group. Blood Transfus. 2024;22(2):176\u201384.","journal-title":"Blood Transfus"},{"issue":"2","key":"4111_CR95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","volume":"26","author":"MJ Grant","year":"2009","unstructured":"Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J. 2009;26(2):91\u2013108.","journal-title":"Health Info Libr J"},{"issue":"3","key":"4111_CR96","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147\u201353.","journal-title":"Int J Evid Based Healthc"},{"issue":"1","key":"4111_CR97","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"issue":"2","key":"4111_CR98","doi-asserted-by":"publisher","first-page":"e12234","DOI":"10.1002\/jcv2.12234","volume":"4","author":"N Fabiano","year":"2024","unstructured":"Fabiano N, Gupta A, Bhambra N, Luu B, Wong S, Maaz M, et al. How to optimize the systematic review process using ai tools. JCPP Adv. 2024;4(2):e12234.","journal-title":"JCPP Adv"},{"key":"4111_CR99","doi-asserted-by":"crossref","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and shiny app for producing prisma 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis Campbell systematic reviews. 2022;18(e1230)","DOI":"10.1002\/cl2.1230"},{"issue":"4","key":"4111_CR100","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4103\/0028-3886.33303","volume":"55","author":"D Kochar","year":"2007","unstructured":"Kochar D, Pal M, Kochar S, Vyas A, Kochar A, Bindal D, et al. Acute intermittent porphyria presenting with neurological emergency: review of six cases. Neurol India. 2007;55(4):413\u201315.","journal-title":"Neurol India"},{"key":"4111_CR101","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/jth.15681","volume":"20","author":"TP Bull","year":"2022","unstructured":"Bull TP, McCulloch R, Nicolson PLR, Doyle AJ, Shaw RJ, Langridge A, et al. Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019. J Thromb Haemostasis. 2022;20:1428\u201336.","journal-title":"J Thromb Haemostasis"},{"issue":"3","key":"4111_CR102","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.transci.2013.04.016","volume":"48","author":"S Korkmaz","year":"2013","unstructured":"Korkmaz S, Keklik M, Sivgin S, Yildirim R, Tombak A, Kaya ME, et al. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study. Tranfus And Apheresis Sci. 2013;48(3):353\u201358.","journal-title":"Tranfus And Apheresis Sci"},{"key":"4111_CR103","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2008.10.037","volume":"200","author":"CL Stella","year":"2009","unstructured":"Stella CL, Dacus J, Guzman E, Dhillon P, Coppage K, How H, et al. The diagnostic dilemma of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome in the obstetric triage and emergency department: lessons from 4 tertiary hospitals. Am J Obstet Gynecol. 2009;200:e1\u2013381.","journal-title":"Am J Obstet Gynecol"},{"key":"4111_CR104","doi-asserted-by":"crossref","unstructured":"Yang J, Chen Q, Yang H, Hua B, Zhu T, Zhao Y, et al. Clinical and laboratory features of acute porphyria: a study of 36 subjects in a Chinese tertiary referral center. Biomed Res Int. 2016;2016(no pagination)","DOI":"10.1155\/2016\/3927635"},{"issue":"2","key":"4111_CR105","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajem.2004.03.013","volume":"23","author":"YP Liu","year":"2005","unstructured":"Liu YP, Lien WC, Fang CC, Lai TI, Chen WJ, Wang HP. Ed presentation of acute porphyria. Am J Emerg Med. 2005;23(2):164\u201367.","journal-title":"Am J Emerg Med"},{"issue":"1","key":"4111_CR106","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0028-3886.60410","volume":"58","author":"S Kumar","year":"2010","unstructured":"Kumar S, Sharma N, Modi M, Sharma A, Mahi S, Varma S. Spectrum of emergency department presentation in patients of acute intermittent porphyria: experience from a North Indian tertiary care center. Neurol India. 2010;58(1):95\u201398.","journal-title":"Neurol India"},{"key":"4111_CR107","first-page":"1349","volume":"30","author":"C Huseyin","year":"2014","unstructured":"Huseyin C, Aykac Cebicci M, Sahan M, Gurbuz S, Karaca B, Karakus A, et al. Triggers for attacks in familial mediterranean fever: are there any regional or ethnic differences? Acta Medica Mediterr. 2014;30:1349\u201353.","journal-title":"Acta Medica Mediterr"},{"issue":"8","key":"4111_CR108","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7196\/SAMJ.2023.v113i8.717","volume":"113","author":"C Day","year":"2023","unstructured":"Day C, Van der Walt J, Crombie K, Hendrikse C, Peter J. Acute angioedema in Cape Town emergency centres and a suggested algorithm to simplify and improve management. S Afr Med J. 2023;113(8):51\u201357.","journal-title":"S Afr Med J"},{"issue":"5","key":"4111_CR109","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2500\/aap.2014.35.3787","volume":"35","author":"S Felder","year":"2014","unstructured":"Felder S, Curtis RM, Ball I, Borici-Mazi R. Prognostic factors in outcome of angioedema in the emergency department. Allergy Asthma Proc. 2014;35(5):362\u201370.","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"4111_CR110","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.anai.2015.04.005","volume":"114","author":"N Javaud","year":"2015","unstructured":"Javaud N, Gompel A, Bouillet L, Boccon-Gibod I, Cantin D, Smaiti N, et al. Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study. Ann of Allergy, Asthma, Immunol. 2015;114(6):499\u2013503.","journal-title":"Ann Of Allergy, Asthma, Immunol"},{"key":"4111_CR111","doi-asserted-by":"crossref","unstructured":"Moldovan D, Bara N, Nadasan V, Gabos G, Mihaly E. Consequences of misdiagnosed and mismanaged hereditary angioedema laryngeal attacks: an overview of cases from the Romanian registry. Case Rep Emerg Med Print. 2018; 2018;6363787.","DOI":"10.1155\/2018\/6363787"},{"issue":"2","key":"4111_CR112","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jemermed.2007.02.024","volume":"33","author":"M Pekdemir","year":"2007","unstructured":"Pekdemir M, Ersel M, Aksay E, Yanturali S, Akturk A, Kiyan S. Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department. J Emerg Med. 2007;33(2):137\u201339.","journal-title":"J Emerg Med"},{"key":"4111_CR113","first-page":"8847030","volume":"2023","author":"M Songur Kodik","year":"2023","unstructured":"Songur Kodik M, Inci O, Cetin ZD, Mete Gokmen EN, Karbek Akarca F. Evaluation of the retrospective lace index in predicting the risk of readmission in patients with hereditary angioedema in an emergency department. Emerg Med Int Print. 2023;2023:8847030.","journal-title":"Emerg Med Int Print"},{"issue":"9","key":"4111_CR114","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2176\/nmc.43.447","volume":"43","author":"K Kuwayama","year":"2003","unstructured":"Kuwayama K, Takase K, Kashihara M, Hondo H, Shigekiyo T, Takimoto O, et al. Central nervous system lesions associated with hereditary hemorrhagic telangiectasia\u2013three case reports. Neurologia medico-chirurgica. 2003;43(9):447\u201351.","journal-title":"Neurologia medico-chirurgica"},{"key":"4111_CR115","doi-asserted-by":"crossref","unstructured":"Boisriou I, Ellouze S, Kassasseya C, Feral-Pierssens AL, Gerlier C, Chauvin A, et al. Misdiagnosis of thrombotic microangiopathy in the emergency department: a multicenter retrospective study. Intern Emerg Med. 2023;1.","DOI":"10.1007\/s11739-023-03457-8"},{"key":"4111_CR116","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ajem.2020.11.019","volume":"46","author":"XM Li","year":"2021","unstructured":"Li XM, Mo XY, Huang GQ, Zhang FJ. Therapeutical plasma exchange for thrombotic thrombocytopenic purpura in the emergency department: a single center experience. Am J Emerg Med. 2021;46:556\u201359.","journal-title":"Am J Emerg Med"},{"key":"4111_CR117","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/qjmed\/hct142","volume":"106","author":"N Noel","year":"2013","unstructured":"Noel N, Maigne G, Tertian G, Anguel N, Monnet X, Michot JM, et al. Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency. Qjm. 2013;106:1017\u201322.","journal-title":"Qjm"},{"key":"4111_CR118","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.itjm.2011.02.003","volume":"5","author":"F Pieralli","year":"2011","unstructured":"Pieralli F, Mancini A, Camaiti A, Berni G, Nozzoli C. The ability of clinical and laboratory findings to predict in-hospital death in patients with thrombotic thrombocytopenic purpura in an internal and emergency medicine department. Italian J Med. 2011;5:269\u201373.","journal-title":"Italian J Med"},{"key":"4111_CR119","first-page":"453","volume":"52","author":"V Goyal","year":"2004","unstructured":"Goyal V, Behari M, Singh S, Srivastava T. Myasthenic crisis: a retrospective study. Neurol India. 2004;52:453\u201356.","journal-title":"Neurol India"},{"key":"4111_CR120","doi-asserted-by":"crossref","unstructured":"Hsu CW, Chen NC, Huang WC, Lin HC, Tsai WC, Huang CC, et al. Hemogram parameters can predict in-hospital mortality of patients with myasthenic crisis. BMC Neurol. 2021;21.","DOI":"10.1186\/s12883-021-02412-4"},{"key":"4111_CR121","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00415-022-11471-7","volume":"270","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Choi JY, Yang HK, Hwang JM, Kim JS. Diplopia: characteristics and etiologic distribution in a referral-based university hospital. J Neurol. 2023;270:1067\u201375.","journal-title":"J Neurol"},{"key":"4111_CR122","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/01658107.2020.1860091","volume":"45","author":"N Kumar","year":"2021","unstructured":"Kumar N, Kaur S, Raj S, Lal V, Sukhija J. Causes and outcomes of patients presenting with Diplopia: a hospital-based study. Neuro-Ophthalmology. 2021;45:238\u201345.","journal-title":"Neuro-Ophthalmology"},{"key":"4111_CR123","first-page":"1608","volume":"34","author":"S Kumar","year":"2020","unstructured":"Kumar S. Acute onset binocular diplopia: a retrospective observational study of 100 consecutive cases managed at a tertiary eye centre in Saudi Arabia. Eye (Basingstoke). 2020;34:1608\u201313.","journal-title":"Eye (Basingstoke)"},{"key":"4111_CR124","first-page":"E32740","volume":"102","author":"T El Zahran","year":"2023","unstructured":"El Zahran T, El Hadi D, Mostafa H, Mansour H, Hashim I, Tahhan S, et al. The yield of neuroimaging in patients presenting to the emergency department with isolated neuro-ophthalmological complaints: a retrospective chart review. Med (U States). 2023;102:E32740.","journal-title":"Med (U States)"},{"issue":"1","key":"4111_CR125","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13023-024-03143-8","volume":"19","author":"M Al-Attar","year":"2024","unstructured":"Al-Attar M, Butterworth S, McKay L. A quantitative and qualitative analysis of patient group narratives suggests common biopsychosocial red flags of undiagnosed rare disease. Orphanet J Rare Dis. 2024;19(1):172.","journal-title":"Orphanet J Rare Dis"},{"key":"4111_CR126","first-page":"31","volume-title":"Elsevier Essentials seltene Erkrankungen: das Wichtigste f\u00fcr \u00c4rztinnen und \u00c4rzte aller Fachrichtungen [Elsevier Essentials rare diseases: the most important information for doctors of all specialities]","author":"L Grigull","year":"2021","unstructured":"Grigull L. Die richtige Recherche bis zur Diagnose [The right research until diagnosis]. In: M\u00fccke M, Conrad R, editors. Elsevier Essentials seltene Erkrankungen: das Wichtigste f\u00fcr \u00c4rztinnen und \u00c4rzte aller Fachrichtungen [Elsevier Essentials rare diseases: the most important information for doctors of all specialities]. Munich, Germany: Elsevier: Urban-&-Fischer-Verlag; 2021. p. 31\u201334."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04111-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04111-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04111-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:58:53Z","timestamp":1781614733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04111-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4111"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04111-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This systematised literature review was undertaken as part of a project including a patient survey regarding rare diseases in the emergency department (BEAWARE, DRKS-ID: DRKS00033032).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare that they have no competing financial or personal interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"582"}}